Abstract
Acinetobacter baumannii is among the most prevalent bacterial causes of combat-related infections on the battlefield. Antibiotic resistance and a poor understanding of the protective host immune responses make treatment difficult. Here, we report the genome sequences of four clinical Acinetobacter baumannii-A. calcoaceticus complex isolates exhibiting significant differences in virulence in a mouse sepsis model.
GENOME ANNOUNCEMENT
Acinetobacter baumannii accounts for >36% of combat-related infections resulting from injuries sustained by military service personnel in the Middle East, making it among the most prevalent bacterial pathogens encountered on the battlefield (1, 2). Ubiquitous in nature, A. baumannii resists desiccation, allowing the pathogen to survive in relatively arid environments most other bacteria cannot (3–5). This, in combination with the increased level of antibiotic resistance associated with A. baumannii and its ability to colonize various bodily sites, makes these infections difficult to control and treat (3, 6–11). The limited genomic plasticity and biochemical conservation among Acinetobacter species pose problems with regard to species identification in clinical settings, resulting in A. baumannii and Acinetobacter calcoaceticus often being reported as the A. baumannii-A. calcoaceticus complex (ABC) (10, 12). Genomic heterogeneity in A. baumannii has an established impact on patient outcome based on variations of the virulence and antibiotic resistance gene alleles present in each strain (13–16).
To this end, we sequenced four clinical multidrug-resistant ABC strains, CI77, CI78, CI79, and CI86, from a collection obtained from respiratory (CI78 and CI79) or wound (CI77 and CI86) cultures from military personnel injured in either Iraq or Afghanistan (17). In a murine sepsis model, we observed significant differences in virulence in vivo between strains CI77 and CI79 correlating to sustained and elevated blood serum levels of an acute-phase small pattern recognition receptor known as PTX3; PTX3 possesses antimicrobial properties following challenge with strain CI79 (P. M. Ketter, M. N. Guentzel, B. Schaffer, M. Herzig, X. Wu, C. G. Fedyk, J. Yu, J. Jorgensen, J. P. Chambers, A. P. Cap, and B. P. Arulanandam, submitted for publication). Genomic DNA was subjected to Illumina sequencing using paired-end libraries with 300-bp inserts on the HiSeq 2000 platform. The draft genome was assembled with the Velvet assembler (18, 19), and the IGS Annotation Engine and Manatee were used for structural and functional genome annotation and visualization of the chromosomes and plasmid contigs (20).
The observed genome sizes of the isolates range from 3.8 to 4.2 Mb, with an average G+C content of 38%. In silico comparison of the 16s rRNA genes allowed the complex and species attribution of CI77, CI79, and CI86 as being pathogenic A. baumannii strains, while CI78 is representative of A. calcoaceticus, is generally considered nonpathogenic, and is found to occasionally colonize but rarely cause infection in humans (10, 12). We determined the carriage of several reported A. baumannii virulence factors, such as LpxC, PglL, and AbaI (21–23), and found only limited genomic plasticity among the analyzed Middle Eastern ABC isolates. The availability of these sequences as a reference in RNAseq analysis will assist in future studies examining alterations in the ABC complex transcriptome and will help enhance our understanding of the underlying genetics and regulatory pathways leading to altered clinical disease manifestation in patients infected with emerging pathogens of ABC.
Nucleotide sequence accession numbers.
The genome sequences of the Acinetobacter clinical isolates CI77, CI78, CI79, and CI86 have been deposited in GenBank under accession no. AVOC00000000, AVOE00000000, AVOD00000000, and AVOB00000000, respectively.
ACKNOWLEDGMENTS
This research was partially funded by the Army Research Office of the Department of Defense (contract no. W911NF-11-1-0136) and the Álvarez Graduate Research Education Excellence Fund. Computational support was provided by the Computational System Biology Core at the University of Texas at San Antonio and the South Texas Center for Emerging Infectious Diseases (STCEID).
The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.
Footnotes
Citation Ketter P, Guentzel MN, Chambers JP, Jorgensen J, Murray CK, Cap AP, Yu J-J, Eppinger M, Arulanandam BP. 2014. Genome sequences of four Acinetobacter baumannii-A. calcoaceticus complex isolates from combat-related infections sustained in the Middle East. Genome Announc. 2(1):e00026-14. doi:10.1128/genomeA.00026-14.
REFERENCES
- 1. Petersen K, Riddle MS, Danko JR, Blazes DL, Hayden R, Tasker SA, Dunne JR. 2007. Trauma-related infections in battlefield casualties from Iraq. Ann. Surg. 245:803–811. 10.1097/01.sla.0000251707.32332.c1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Tribble DR, Conger NG, Fraser S, Gleeson TD, Wilkins K, Antonille T, Weintrob A, Ganesan A, Gaskins LJ, Li P, Grandits G, Landrum ML, Hospenthal DR, Millar EV, Blackbourne LH, Dunne JR, Craft D, Mende K, Wortmann GW, Herlihy R, McDonald J, Murray CK. 2011. Infection-associated clinical outcomes in hospitalized medical evacuees after traumatic injury: trauma infectious disease outcome study. J. Trauma 71:S33–S42. 10.1097/TA.0b013e318221162e [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Bergogne-Bérézin E, Towner KJ. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148–165 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Fournier PE, Richet H. 2006. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin. Infect. Dis. 42:692–699. 10.1086/500202 [DOI] [PubMed] [Google Scholar]
- 5. Baumann P. 1968. Isolation of Acinetobacter from soil and water. J. Bacteriol. 96:39–42 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Koeleman JG, van der Bijl MW, Stoof J, Vandenbroucke-Grauls CM, Savelkoul PH. 2001. Antibiotic resistance is a major risk factor for epidemic behavior of Acinetobacter baumannii. Infect. Control Hosp. Epidemiol. 22:284–288. 10.1086/501901 [DOI] [PubMed] [Google Scholar]
- 7. Cisneros JM, Reyes MJ, Pachón J, Becerril B, Caballero FJ, García-Garmendia JL, Ortiz C, Cobacho AR. 1996. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin. Infect. Dis. 22:1026–1032. 10.1093/clinids/22.6.1026 [DOI] [PubMed] [Google Scholar]
- 8. Dy ME, Nord JA, LaBombardi VJ, Kislak JW. 1999. The emergence of resistant strains of Acinetobacter baumannii: clinical and infection control implications. Infect. Control Hosp. Epidemiol. 20:565–567. 10.1086/501673 [DOI] [PubMed] [Google Scholar]
- 9. Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y. 2005. Multidrug-resistant Acinetobacter baumannii. Emerg. Infect. Dis. 11:22–29. 10.3201/eid1101.040001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Peleg AY, de Breij A, Adams MD, Cerqueira GM, Mocali S, Galardini M, Nibbering PH, Earl AM, Ward DV, Paterson DL, Seifert H, Dijkshoorn L. 2012. The success of Acinetobacter species; genetic, metabolic and virulence attributes. PLoS One 7:e46984. 10.1371/journal.pone.0046984 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Hospenthal DR, Crouch HK, English JF, Leach F, Pool J, Conger NG, Whitman TJ, Wortmann GW, Robertson JL, Murray CK. 2011. Multidrug-resistant bacterial colonization of combat-injured personnel at admission to medical centers after evacuation from Afghanistan and Iraq. J. Trauma 71:S52–S57. 10.1097/TA.0b013e31822118fb [DOI] [PubMed] [Google Scholar]
- 12. Chiang MC, Kuo SC, Chen YC, Lee YT, Chen TL, Fung CP. 2011. Polymerase chain reaction assay for the detection of Acinetobacter baumannii in endotracheal aspirates from patients in the intensive care unit. J. Microbiol. Immunol. Infect. 44:106–110. 10.1016/j.jmii.2010.04.003 [DOI] [PubMed] [Google Scholar]
- 13. Sahl JW, Johnson JK, Harris AD, Phillippy AM, Hsiao WW, Thom KA, Rasko DA. 2011. Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity. BMC Genomics 12:291. 10.1186/1471-2164-12-291 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Kang G, Hartzell JD, Howard R, Wood-Morris RN, Johnson MD, Fraser S, Weintrob A, Wortmann G. 2010. Mortality associated with Acinetobacter baumannii complex bacteremia among patients with war-related trauma. Infect. Control Hosp. Epidemiol. 31:92–94. 10.1086/649220 [DOI] [PubMed] [Google Scholar]
- 15. Johnson EN, Burns TC, Hayda RA, Hospenthal DR, Murray CK. 2007. Infectious complications of open type III tibial fractures among combat casualties. Clin. Infect. Dis. 45:409–415. 10.1086/520029 [DOI] [PubMed] [Google Scholar]
- 16. Albrecht MC, Albrecht MA, Griffith ME, Murray CK, Chung KK, Horvath EE, Ward JA, Hospenthal DR, Holcomb JB. 2006. Impact of Acinetobacter infection on the mortality of burn patients. J. Am. Coll. Surg. 203:546–550. 10.1016/j.jamcollsurg.2006.06.013 [DOI] [PubMed] [Google Scholar]
- 17. Hawley JS, Murray CK, Griffith ME, McElmeel ML, Fulcher LC, Hospenthal DR, Jorgensen JH. 2007. Susceptibility of Acinetobacter strains isolated from deployed U.S. military personnel. Antimicrob. Agents Chemother. 51:376–378. 10.1128/AAC.00858-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Zerbino DR. 2002. Using the Velvet de novo assembler for short-read sequencing technologies, Curr. Protoc. Bioinformatics 31:11.5.1–11.5.12. 10.1002/0471250953.bi1105s31 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Zerbino DR, Birney E. 2008. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 18:821–829. 10.1101/gr.074492.107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Galens K, Orvis J, Daugherty S, Creasy HH, Angiuoli S, White O, Wortman J, Mahurkar A, Gwinn Giglio M. 2011. The IGS standard operating procedure for automated prokaryotic annotation. Stand. Genomic Sci. 4:244–251. 10.4056/sigs.1223234 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Iwashkiw JA, Seper A, Weber BS, Scott NE, Vinogradov E, Stratilo C, Reiz B, Cordwell SJ, Whittal R, Schild S, Feldman MF. 2012. Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation. PLoS Pathog. 8:e1002758. 10.1371/journal.ppat.1002758 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Lin L, Tan B, Pantapalangkoor P, Ho T, Baquir B, Tomaras A, Montgomery JI, Reilly U, Barbacci EG, Hujer K, Bonomo RA, Fernandez L, Hancock RE, Adams MD, French SW, Buslon VS, Spellberg B. 2012. Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis. mBio 3(5):e00312-12. 10.1128/mBio.00312-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Niu C, Clemmer KM, Bonomo RA, Rather PN. 2008. Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii. J. Bacteriol. 190:3386–3392. 10.1128/JB.01929-07 [DOI] [PMC free article] [PubMed] [Google Scholar]